Join experts as they provide information and answer questions about kidney cancer to help patients and caregivers compare, discuss, and select treatment options with their doctor. See list below for topics discussed. Please note that this is a not an accredited activity.

Topics Discussed:
00:00 - Welcome and Introductions
01:59 - Epidemiology
05:13 - Stages and Types of Kidney Cancer
09:55 - Diagnosis and Management Options
27:22 - Side Effects from Systemic Therapy
37:54 - Side Effects of Common Drugs
38:19 - Immunotherapy (IV) Side Effects
39:31 - Resources for Kidney Cancer Patients
40:09 - KidneyCAN (Patient Advocacy Group)
54:38 - Question and Answer Session
1:12:38 - Closing Remarks

Question and Answer Session:
54:38 - Thoughts on kidney regeneration and the klotho protein for people with kidney cancer and chronic kidney disease?
56:37 - Is there a hereditary or inheritance test for kidney cancer?
58:13 - Is there a way to treat benign cysts on kidneys without surgery? Should they be left as is?
59:09 - What is the recommended treatment for translocation renal cell carcinoma (RCC)? Can you discuss prognosis, follow up testing and timing for adult patients?
1:00:38 - What are the risks and benefits of immunotherapy for translocation renal cell carcinoma?
1:01:26 - New treatments for Birt-Hogg-Dubé syndrome?
1:02:09 - Is Stage 4 kidney cancer with slow growing cancer common?
1:03:53 - Is a PET scan the best way to find new reoccurrence?
1:05:42 - How is a non-healing rectal wound managed after tyrosine kinase inhibitors (TKI) impembro?
1:06:21 - What are signs to look for if immunotherapy is no longer working and needs to be changed?
1:07:25 - Can one receive immunotherapy indefinitely or should it be discontinued after a period of time?
1:09:09 - Is it possible to receive treatment for RCC while on dialysis?
1:09:53 - Considering the side effects and risks immunotherapy may cause, is it possible to only use targeted therapy first, and when it reaches drug resistance, change to immunotherapy? Will it lower the efficacy of immunotherapy?
1:11:02 - Where can you find more information on chromophobe RCC?

The Patient Webinar: Kidney Cancer occurred in February 2022. This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Kidney Cancer. ([ Ссылка ])

The NCCN Guidelines for Patients ([ Ссылка ]) are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.

NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.

Supporters:
This webinar is supported through the NCCN Foundation® and by contributions from our corporate supporters: Bristol Myers Squibb; Eisai, Inc.; Exelixis, Inc.; and Pfizer Inc.
________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit [ Ссылка ]
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit [ Ссылка ] for more information.

Subscribe to our channel for the latest in cancer care: [ Ссылка ]

Connect with us!
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]

свернуть